Antiplatelet effect of amlodipine - A possible mechanism through a nitric oxide,mediated process

被引:22
作者
Chou, TC
Li, CY
Yen, MH
Ding, YA
机构
[1] Tri Serv Gen Hosp, Grad Inst Med Sci, Natl Def Med Ctr, Taipei, Taiwan
[2] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Anesthesiol, Taipei, Taiwan
[3] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan
[4] Vet Gen Hosp Taipei, Dept Cardiol, Taipei, Taiwan
关键词
amlodipine; nitric oxide; guanosine; 3; 5 '-cyclic monophosphate; thromboxane B-2; platelet aggregation;
D O I
10.1016/S0006-2952(99)00235-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of amlodipine, a novel calcium channel blocker of the dihydropyridine type, on rabbit platelet aggregation, and the possible antiaggregatory mechanisms of amlodipine, especially on the nitric oxide (NO) guanosine 3',5'-cyclic monophosphate (cyclic GMP)-mediated pathway, were investigated. Other effects of amlodipine on thromboxane B-2 (TXB2) formation in platelets also were examined. Amlodipine concentration-dependently inhibited rabbit platelet aggregation induced by collagen (10 mu g/mL) or thrombin (0.1 U/mL) with an IC50 range of 32-69 mu M. Along with this inhibition, our results also demonstrated that in the presence of L-arginine (100 mu M), amlodipine (50 mu M) increased nitric oxide synthetase (NOS) activity (from the resting activity of 2.05 +/- 0.36 to 7.11 +/- 0.95 pmol/mg protein/min) and NO release (by 80%), accompanied by an elevation of the cyclic GMP level (from the resting platelet level of 1.27 +/- 0.12 to 6.21 +/- 0.55 pmol/10(9) platelets) induced by collagen (10 mu g/mL). However, the antiaggregatory effect of amlodipine (50 mu M) could be attenuated significantly by oxyhemoglobin (5 mu M), a NO scavenger, or NG-nitro-L-arginine methyl ester (100 mu M), a specific NOS inhibitor. In addition, the TXB2 production in platelets induced by collagen or thrombin was concentration-dependently inhibited by amlodipine. Therefore, we propose that: the antiaggregatory mechanisms of amlodipine might be mediated, in part, by a NO-cyclic GMP process accompanied by the inhibition of TXB2 formation in platelets. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:1657 / 1663
页数:7
相关论文
共 39 条
[21]  
MELLION BT, 1981, BLOOD, V57, P946
[22]   STUDIES ON THE IMPORTANCE OF THE PROPOSED RELEASE OF NITRIC-OXIDE FROM PLATELETS [J].
MOLLACE, V ;
SALVEMINI, D ;
VANE, J .
THROMBOSIS RESEARCH, 1991, 64 (05) :533-542
[23]  
Mustard J F, 1976, Trans Am Clin Climatol Assoc, V87, P104
[24]   INHIBITORY-ACTION OF CYCLIC-GMP ON SECRETION, POLYPHOSPHOINOSITIDE HYDROLYSIS AND CALCIUM MOBILIZATION IN THROMBIN-STIMULATED HUMAN-PLATELETS [J].
NAKASHIMA, S ;
TOHMATSU, T ;
HATTORI, H ;
OKANO, Y ;
NOZAWA, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 135 (03) :1099-1104
[25]   INTERACTION OF NITRIC-OXIDE AND CGMP WITH SIGNAL TRANSDUCTION IN ACTIVATED PLATELETS [J].
NGUYEN, BL ;
SAITOH, M ;
WARE, JA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (04) :H1043-H1052
[26]   Effect of amlodipine on morbidity and mortality in severe chronic heart failure [J].
Packer, M ;
OConnor, CM ;
Ghali, JK ;
Pressler, ML ;
Carson, PE ;
Belkin, RN ;
Miller, AB ;
Neuberg, GW ;
Frid, D ;
Wertheimer, JH ;
Cropp, AB ;
DeMets, DL .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (15) :1107-1114
[27]  
PACKHAM MA, 1986, SEMIN HEMATOL, V23, P8
[28]   EFFECTS OF DIHYDROPYRIDINES AND INORGANIC CALCIUM BLOCKERS ON AGGREGATION AND ON INTRACELLULAR FREE CALCIUM IN PLATELETS [J].
PALES, J ;
PALACIOSARAUS, L ;
LOPEZ, A ;
GUAL, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1064 (02) :169-174
[29]   AN L-ARGININE NITRIC-OXIDE PATHWAY PRESENT IN HUMAN PLATELETS REGULATES AGGREGATION [J].
RADOMSKI, MW ;
PALMER, RMJ ;
MONCADA, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) :5193-5197
[30]  
RADOMSKI MW, 1993, ADV EXP MED BIOL, V344, P251